Loading candles…
Avience Biomedicals Limited is an ISO-certified company specializing in molecular diagnostics, biotechnology, genomics, and in-vitro diagnostics (IVD). Established in 2019, it manufactures, supplies, and exports diagnostic solutions, including rapid test kits, molecular diagnostic kits, biochemistry and hematology analyzers, medical devices, and diagnostic reagents. The company serves pathology laboratories, hospitals, microbiology labs, and research centers in India and internationally. Its manufacturing facility is located in Noida, Uttar Pradesh. As of January 31, 2026, Avience Biomedicals employed 75 permanent and 33 contractual staff. The company's leadership includes Managing Director Dharam Deo Choudhary, Directors Deepa Choudhary and Janardan Pal, and promoter Ram Nagina Choudhary.
This page is a live market overview for AVIENCE BIOMEDICALS LTD (AVIENCE) on the NSE. As a listed security, AVIENCE BIOMEDICALS LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AVIENCE before placing trades on tick2trade.
As of the latest feed, AVIENCE last traded at ₹341 on NSE, up ₹2.8 (0.83%) from the previous close of ₹338.2. Today's session range is ₹339.95 – ₹348, against a 52-week band of ₹222 – ₹414.95. Traded volume today stands at 10.20K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, upcoming corporate events for AVIENCE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AVIENCE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for AVIENCE BIOMEDICALS LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AVIENCE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AVIENCE option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.